Viewing Study NCT00913367


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2026-01-01 @ 3:24 PM
Study NCT ID: NCT00913367
Status: COMPLETED
Last Update Posted: 2013-03-28
First Post: 2009-05-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus
Sponsor: Handok Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 Diabetes Mellitus View